182 related articles for article (PubMed ID: 26187749)
1. Alternative signaling network activation through different insulin receptor family members caused by pro-mitogenic antidiabetic insulin analogues in human mammary epithelial cells.
ter Braak B; Wink S; Koedoot E; Pont C; Siezen C; van der Laan JW; van de Water B
Breast Cancer Res; 2015 Jul; 17(1):97. PubMed ID: 26187749
[TBL] [Abstract][Full Text] [Related]
2. Classifying the adverse mitogenic mode of action of insulin analogues using a novel mechanism-based genetically engineered human breast cancer cell panel.
ter Braak B; Siezen CL; Kannegieter N; Koedoot E; van de Water B; van der Laan JW
Arch Toxicol; 2014 Apr; 88(4):953-66. PubMed ID: 24464500
[TBL] [Abstract][Full Text] [Related]
3. Mammary gland tumor promotion by chronic administration of IGF1 and the insulin analogue AspB10 in the p53R270H/⁺WAPCre mouse model.
ter Braak B; Siezen C; Speksnijder EN; Koedoot E; van Steeg H; Salvatori DC; van de Water B; van der Laan JW
Breast Cancer Res; 2015 Feb; 17(1):14. PubMed ID: 25848982
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factor 1 receptor activation promotes mammary gland tumor development by increasing glycolysis and promoting biomass production.
Ter Braak B; Siezen CL; Lee JS; Rao P; Voorhoeve C; Ruppin E; van der Laan JW; van de Water B
Breast Cancer Res; 2017 Feb; 19(1):14. PubMed ID: 28173837
[TBL] [Abstract][Full Text] [Related]
5. Controlled dimerization of insulin-like growth factor-1 and insulin receptors reveals shared and distinct activities of holo and hybrid receptors.
Chen J; Nagle AM; Wang YF; Boone DN; Lee AV
J Biol Chem; 2018 Mar; 293(10):3700-3709. PubMed ID: 29330302
[TBL] [Abstract][Full Text] [Related]
6. Insulin and its analogues and their affinities for the IGF1 receptor.
Varewijck AJ; Janssen JA
Endocr Relat Cancer; 2012 Oct; 19(5):F63-75. PubMed ID: 22420005
[TBL] [Abstract][Full Text] [Related]
7. Surface-expressed insulin receptors as well as IGF-I receptors both contribute to the mitogenic effects of human insulin and its analogues.
Lundby A; Bolvig P; Hegelund AC; Hansen BF; Worm J; Lützen A; Billestrup N; Bonnesen C; Oleksiewicz MB
J Appl Toxicol; 2015 Jul; 35(7):842-50. PubMed ID: 25413577
[TBL] [Abstract][Full Text] [Related]
8. A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.
Sachdev D; Li SL; Hartell JS; Fujita-Yamaguchi Y; Miller JS; Yee D
Cancer Res; 2003 Feb; 63(3):627-35. PubMed ID: 12566306
[TBL] [Abstract][Full Text] [Related]
9. Review on the in vitro interaction of insulin glargine with the insulin/insulin-like growth factor system: potential implications for metabolic and mitogenic activities.
Ciaraldi TP; Sasaoka T
Horm Metab Res; 2011 Jan; 43(1):1-10. PubMed ID: 20938889
[TBL] [Abstract][Full Text] [Related]
10. Proliferative effects of insulin analogues on mammary epithelial cells.
Mayer D; Shukla A; Enzmann H
Arch Physiol Biochem; 2008 Feb; 114(1):38-44. PubMed ID: 18465357
[TBL] [Abstract][Full Text] [Related]
11. Activation of insulin receptors and IGF-1 receptors in COLO-205 colon cancer xenografts by insulin and insulin analogue X10 does not enhance growth under normo- or hypoglycaemic conditions.
Hvid H; Jørgensen MS; Blume N; Slaaby R; Lützen A; Hansen BF
Diabetologia; 2018 Nov; 61(11):2447-2457. PubMed ID: 30003309
[TBL] [Abstract][Full Text] [Related]
12. Analysis of signaling pathways related to cell proliferation stimulated by insulin analogs in human mammary epithelial cell lines.
Shukla A; Grisouard J; Ehemann V; Hermani A; Enzmann H; Mayer D
Endocr Relat Cancer; 2009 Jun; 16(2):429-41. PubMed ID: 19153208
[TBL] [Abstract][Full Text] [Related]
13. Proliferative and signaling activities of insulin analogues in endometrial cancer cells.
Aizen D; Sarfstein R; Bruchim I; Weinstein D; Laron Z; Werner H
Mol Cell Endocrinol; 2015 May; 406():27-39. PubMed ID: 25697343
[TBL] [Abstract][Full Text] [Related]
14. Differential Effects of Insulin and IGF1 Receptors on ERK and AKT Subcellular Distribution in Breast Cancer Cells.
Sarfstein R; Nagaraj K; LeRoith D; Werner H
Cells; 2019 Nov; 8(12):. PubMed ID: 31771180
[TBL] [Abstract][Full Text] [Related]
15. Insulin glargine and receptor-mediated signalling: clinical implications in treating type 2 diabetes.
Le Roith D
Diabetes Metab Res Rev; 2007 Nov; 23(8):593-9. PubMed ID: 17922476
[TBL] [Abstract][Full Text] [Related]
16. Highly specific role of the insulin receptor in breast cancer progression.
Rostoker R; Abelson S; Bitton-Worms K; Genkin I; Ben-Shmuel S; Dakwar M; Orr ZS; Caspi A; Tzukerman M; LeRoith D
Endocr Relat Cancer; 2015 Apr; 22(2):145-57. PubMed ID: 25694511
[TBL] [Abstract][Full Text] [Related]
17. Proliferative effect of Apidra (insulin glulisine), a rapid-acting insulin analogue on mammary epithelial cells.
Shukla A; Enzmann H; Mayer D
Arch Physiol Biochem; 2009 Jul; 115(3):119-26. PubMed ID: 19480564
[TBL] [Abstract][Full Text] [Related]
18. Mitogenic potency of insulin glargine.
Zełobowska K; Gumprecht J; Grzeszczak W
Endokrynol Pol; 2009; 60(1):34-9. PubMed ID: 19224503
[TBL] [Abstract][Full Text] [Related]
19. Effect of insulin analogues on insulin/IGF1 hybrid receptors: increased activation by glargine but not by its metabolites M1 and M2.
Pierre-Eugene C; Pagesy P; Nguyen TT; Neuillé M; Tschank G; Tennagels N; Hampe C; Issad T
PLoS One; 2012; 7(7):e41992. PubMed ID: 22848683
[TBL] [Abstract][Full Text] [Related]
20. A framework for the in vitro evaluation of cancer-relevant molecular characteristics and mitogenic potency of insulin analogues.
Baricevic I; Jones DR; Roberts DL; Lutzen A; Lundby A; Worm J; Hansen BF; Renehan AG
Carcinogenesis; 2015 Sep; 36(9):1040-50. PubMed ID: 26026165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
